EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for XAIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 -0.7738
December 31, 2025 -0.8514
September 30, 2025 -1.249
June 30, 2025 -1.534
March 31, 2025 -1.786
December 31, 2024 -2.959
September 30, 2024 -0.2835
June 30, 2024 -0.2658
March 31, 2024 -0.3572
December 31, 2023 -0.4996
September 30, 2023 -0.5101
June 30, 2023 -0.4491
March 31, 2023 -0.6561
December 31, 2022 -0.426
September 30, 2022 -0.4003
June 30, 2022 -0.3658
March 31, 2022 -0.6698
December 31, 2021 -0.2885
September 30, 2021 -0.3597
June 30, 2021 -0.3073
Date Value
March 31, 2021 -0.2379
December 31, 2020 -0.3276
September 30, 2020 -0.2997
June 30, 2020 -0.4079
March 31, 2020 -0.3581
December 31, 2019 -0.4315
September 30, 2019 -0.383
June 30, 2019 -0.6717
March 31, 2019 -0.0066
December 31, 2018 -5.548
September 30, 2018 -5.661
June 30, 2018 -4.104
December 31, 2017 -0.28
September 30, 2017 -1.18
June 30, 2017 -0.46
March 31, 2017 -0.9988
September 30, 2016 -1.78
June 30, 2016 -43.94
March 31, 2016 -0.025

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Accuray, Inc. -0.095
ResMed, Inc. 2.736
Rockwell Medical, Inc. -0.4072
Microbot Medical, Inc. -0.0547
Stereotaxis, Inc. -0.0624